Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TAK | ZTS | NBIX | ||
| Company | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 13.16 | 151.63 | 133.23 | ||
| High | 13.23 | 153.67 | 134.20 | ||
| Low | 13.12 | 151.17 | 131.00 | ||
| Last | 13.16 | 153.11 | 132.54 | ||
| Change | +0.01 | +1.60 | -0.69 | ||
| % Change | +0.08% | +1.06% | -0.52% | ||
| Volume | 1,287,700 | 4,772,900 | 586,500 | ||
| 20-Day Average Volume | 1,855,360 | 3,894,480 | 859,780 | ||
| Previous Close | 13.15 | 151.51 | 133.23 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.69 | 162.57 | 137.66 | ||
| 20-Day Raw Stochastic | 3.52% | 17.91% | 8.87% | ||
| 20-Day Relative Strength | 32.77% | 31.45% | 43.06% | ||
| Weighted Alpha | -22.35 | -19.08 | +28.59 | ||
| Today's Opinion | 100% Sell | 88% Sell | 40% Buy | ||
| Previous Opinion | 100% Sell | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 48% Sell | 8% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.09% since 04/11/24 | -5.91% since 04/11/24 | -2.49% since 04/11/24 | ||
| Low | 13.11 on 04/17/24 | 148.48 on 04/12/24 | 131.00 on 04/18/24 | ||
| High | 13.56 on 04/12/24 | 155.98 on 04/12/24 | 137.78 on 04/12/24 | ||
| 1-Month | |||||
| %Chg | -9.62% since 03/18/24 | -10.30% since 03/18/24 | -4.95% since 03/18/24 | ||
| Low | 13.11 on 04/17/24 | 148.48 on 04/12/24 | 131.00 on 04/18/24 | ||
| High | 14.55 on 03/20/24 | 174.33 on 03/21/24 | 148.37 on 03/21/24 | ||
| 3-Month | |||||
| %Chg | -11.50% since 01/18/24 | -19.63% since 01/18/24 | -3.08% since 01/18/24 | ||
| Low | 13.11 on 04/17/24 | 148.48 on 04/12/24 | 128.00 on 02/07/24 | ||
| High | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 148.37 on 03/21/24 | ||
| 6-Month | |||||
| %Chg | -10.05% since 10/18/23 | -9.69% since 10/18/23 | +18.11% since 10/18/23 | ||
| Low | 13.11 on 04/17/24 | 148.48 on 04/12/24 | 103.63 on 11/10/23 | ||
| High | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 148.37 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 41,617,356 | 69,491,128 | 13,257,318 | ||
| Shares Outstanding, K | 3,164,818 | 457,359 | 99,507 | ||
| Annual Sales | 29,803,340,000 | 8,544,000,000 | 1,887,100,000 | ||
| Annual Net Income | 2,345,930,000 | 2,344,000,000 | 249,700,000 | ||
| Last Quarter Sales | 7,556,070,000 | 2,213,000,000 | 515,200,000 | ||
| Last Quarter Net Income | 718,900,000 | 525,000,000 | 147,700,000 | ||
| 60-Month Beta | 0.53 | 0.85 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.51 on 02/01/24 | 1.24 on 02/13/24 | 1.44 on 02/07/24 | ||
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/01/24 | ||
| Most Recent Dividend | 0.261 on 09/28/23 | 0.432 on 04/18/24 | N/A | ||
| Next Ex-Dividends Date | 09/28/23 | 04/18/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.78 | 28.76 | 54.95 | ||